2024-515935-31-04RecruitingPhase 1
A positron emission tomography study of synaptic nerve cells proteins alpha-7 nicotinic acetylcholine receptors in brain of healthy volunteers and patients with mild cognitive impairment and Alzheimer´s disease.
Source: EU CTIS (euclinicaltrials.eu) · Last updated 18 Mar 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- First submitted
- 23 Jun 2025
- Start date
- 16 Feb 2026
- Lead sponsor
- Karolinska Institutet
- Diseases
- Alzheimer disease
- EU CT number
- 2024-515935-31-04
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 45
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (3)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karolinska Institutet | Huddinge | Sweden | Recruiting |
| Karolinska Institutet | Solna | Sweden | Recruiting |
| CTC Clinical Trial Consultants AB | Solna | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.